Allotment is out. Check your result on the Mahamaya Lifesciences SME IPO Allotment Status page.
Mahamaya Lifesciences SME logo

Mahamaya Lifesciences SME IPO Subscription

Listed

Updated 18 November 2025, 9:15 AM IST· BSE SME

Mahamaya Lifesciences SME IPO subscription closed on 13 November 2025 at 1.63x overall by shares. QIB demand came in at 1.19x, NII at 3.99x, and retail at 1.02x. See Retail, SHNI, and BHNI allotment chances in the table…

Show more

Allotment date is 14 November 2025. Listing date on NSE and BSE is 18 November 2025.

Issue Price
Rs 114.00
GMP Today
-
Overall Sub
1.63x
Issue Size
₹66.91 Cr
Allotment
14 Nov 2025
Listing
18 Nov 2025

Mahamaya Lifesciences SME IPO Day-wise Subscription

Daily QIB, NII, Retail, and overall subscription as bids come in

DayQIBNIIRetailOverall
Day 1 - 11 Nov 20250.00x0.35x0.07x0.11x
Day 2 - 12 Nov 20250.65x0.27x0.20x0.34x
Day 3 - 13 Nov 20251.19x3.63x1.02x1.63x

Mahamaya Lifesciences SME IPO Allotment Chances

Retail, SHNI, and BHNI chances based on application subscription

Mahamaya Lifesciences SME IPO allotment chances for Retail, SHNI, and BHNI. All three use lottery when the category is oversubscribed.

CategorySubscription (Apps)Allotment Chances
Retail (IND)1.02x1 in 1
SHNI (Rs 2L to Rs 10L)0.77xVery high
BHNI (above Rs 10L)0.51xVery high

Chances use application subscription (how many bids came in), not share or amount figures. If you get allotment, you get at least one lot. Higher subscription means lower chance per PAN.

Check the Mahamaya Lifesciences SME IPO Allotment Status page from 14 November 2025 for your result.

Mahamaya Lifesciences SME IPO Subscription by Amount

Category-wise subscription based on amount applied at issue price Rs 114.00

CategoryAmount OfferedAmount AppliedSubscription
QIBRs 13.41 CrRs 15.98 Cr1.19x
FII-Rs 6.66 Cr-
DFI---
Mutual Funds---
Other-Rs 9.32 Cr-
NIIRs 10.05 CrRs 40.07 Cr3.99x
bNII (above Rs 10L)Rs 6.70 CrRs 37.06 Cr5.53x
Corporate-Rs 8.56 Cr-
Individual-Rs 25.54 Cr-
Other-Rs 2.95 Cr-
sNII (Rs 2L to Rs 10L)Rs 3.35 CrRs 3.01 Cr0.90x
Corporate-Rs 8.21 L-
Individual-Rs 2.93 Cr-
Other---
INDRs 23.47 CrRs 24.02 Cr1.02x
Fixed price-Rs 24.02 Cr-
TotalRs 46.94 CrRs 80.07 Cr1.71x

Mahamaya Lifesciences SME IPO Subscription by Applications

Category-wise subscription based on applications received

CategoryApplications OfferedApplications ReceivedSubscription
QIB98090.01x
FII-2-
DFI---
Mutual Funds---
Other-7-
NII2451460.60x
bNII (above Rs 10L)163830.51x
Corporate-17-
Individual-39-
Other-27-
sNII (Rs 2L to Rs 10L)82630.77x
Corporate-2-
Individual-61-
Other---
IND8588781.02x
Fixed price-878-
Total2,0831,0330.50x

What Do These Subscription Numbers Mean?

1.63x overall by shares means bids covered about 2 times the shares on offer. Allotment chances depend on applications in each category.

QIB at 1.19x by shares shows institutional demand from mutual funds, FIIs, and banks.

NII covers bids above Rs 2 lakh (0.60x by applications). Split: SHNI 0.77x, BHNI 0.51x by applications. SHNI and BHNI allotment is by lottery.

At 1.02x subscription by applications, about 1 in 1 retail applicants may get allotment (~98% chance per application). Retail allotment is also by lottery.

Mahamaya Lifesciences SME IPO Key Dates

EventDate
IPO Open Date11 November 2025
IPO Close Date13 November 2025
Allotment Date14 November 2025
Refund Initiation15 November 2025
Share Credit to Demat15 November 2025
Listing Date18 November 2025
Minimum InvestmentRs 2,73,600.00
Lot Size1200 shares

About Mahamaya Lifesciences SME

No company information available

Understanding Subscription Categories

QIB - Qualified Institutional Buyers

Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.

NII - Non-Institutional Investors (SHNI & BHNI)

Investors bidding above Rs 2 lakh. Split into SHNI (Rs 2 lakh to Rs 10 lakh) and BHNI (above Rs 10 lakh). Both use lottery allotment when oversubscribed.

IND - Individual Investors

Investors bidding up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Winners get at least one lot.

Advertisement

Mahamaya Lifesciences SME IPO Subscription FAQs

What is Mahamaya Lifesciences SME IPO subscription status today?

Mahamaya Lifesciences SME IPO subscription closed on 13 November 2025 with overall subscription of 1.63x (by shares) as of 27 August 2026, 4:32 AM IST. QIB 1.19x, NII 0.60x, IND 1.02x.

What is the overall subscription of Mahamaya Lifesciences SME IPO?

Mahamaya Lifesciences SME IPO is subscribed 1.63x overall by shares at close on 13 November 2025. QIB 1.19x, NII 0.60x, and IND 1.02x.

What is Mahamaya Lifesciences SME IPO QIB subscription?

Mahamaya Lifesciences SME IPO QIB (Qualified Institutional Buyers) subscription is 1.19x by shares. QIB includes mutual funds, FIIs, banks, and other institutions.

What is Mahamaya Lifesciences SME IPO IND subscription?

Mahamaya Lifesciences SME IPO IND subscription is 1.02x by applications. Retail bids are up to Rs 2 lakh per PAN.

What is Mahamaya Lifesciences SME IPO NII, SHNI, and BHNI subscription?

Mahamaya Lifesciences SME IPO NII subscription is 0.60x by applications. NII is bids above Rs 2 lakh, split into SHNI (Rs 2L to Rs 10L) at 0.77x and BHNI (above Rs 10L) at 0.51x.

What are Mahamaya Lifesciences SME IPO retail allotment chances?

At 1.02x subscription by applications, about 1 in 1 retail applicants may get allotment (~98% chance per application). Allotment is by lottery.

What are Mahamaya Lifesciences SME IPO SHNI allotment chances?

Mahamaya Lifesciences SME IPO SHNI allotment chances depend on final application subscription. Allotment is by lottery when oversubscribed.

What are Mahamaya Lifesciences SME IPO BHNI allotment chances?

Mahamaya Lifesciences SME IPO BHNI share subscription is 5.53x. Application data is needed for exact lottery chances.

When is Mahamaya Lifesciences SME IPO allotment date?

Mahamaya Lifesciences SME IPO allotment date is 14 November 2025. Check Mahamaya Lifesciences SME IPO Allotment Status on IPOwiz from that day using your PAN.

When does Mahamaya Lifesciences SME IPO subscription close?

Mahamaya Lifesciences SME IPO subscription closed on 13 November 2025. No new applications are accepted after the close.

What is Mahamaya Lifesciences SME IPO GMP today?

GMP for Mahamaya Lifesciences SME IPO is not available yet. Track Mahamaya Lifesciences SME IPO GMP Today on IPOwiz once grey market activity starts.

What is Mahamaya Lifesciences SME IPO issue price and lot size?

Mahamaya Lifesciences SME IPO issue price is ₹114 per share. Lot size is 1200 shares. Minimum investment is ₹2,73,600 per lot (minimum 2 lots for SME). Issue size: ₹66.91 Cr.

When is Mahamaya Lifesciences SME IPO listing date?

Mahamaya Lifesciences SME IPO listing date is 18 November 2025 on NSE and BSE. Allotment is on 14 November 2025.

How does subscription affect Mahamaya Lifesciences SME IPO allotment?

In Mahamaya Lifesciences SME IPO, Retail, SHNI, and BHNI allotment is by lottery when oversubscribed. Chances follow application subscription in each category, not share volume. At 1.63x overall, competition is moderate.

For allotment results from 14 November 2025, visit the Mahamaya Lifesciences SME IPO Allotment Status page. For listing day updates on 18 November 2025, download the IPOwiz App.

Sources

We match Mahamaya Lifesciences SME IPO numbers with official sources. For final dates and allotment results, double-check the registrar or exchange.

  • SEBIRules for IPO allotment and disclosures in India
  • NSEExchange notices, bidding data, and listing updates
  • BSEExchange notices and IPO allotment check tools
  • RHP / Offer DocumentCheck the company RHP on NSE/BSE or the IPO detail page
  • IPO RegistrarRegistrar details are on the allotment page for this IPO

Also read our Editorial Policy, How GMP is calculated, How allotment chances work, and IPO fund allocation.

Reviewed by

Dinesh Agrawal · Lead IPO Analyst

15+ years in Indian markets and IPO research. He reviews subscription data before it goes live.